Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.99B | 2.89B | 2.79B | 2.74B | 2.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.99B | 2.89B | 2.79B | 2.74B | 2.72B |
| Cost of Revenue | 2.28B | 2.20B | 2.13B | 2.10B | 2.08B |
| Gross Profit | 705.60M | 693.90M | 668.80M | 647.50M | 638.20M |
| SG&A Expenses | 123.60M | 131.20M | 122.10M | 120.90M | 128.70M |
| Depreciation & Amortization | 149.80M | 128.50M | 118.10M | 118.10M | 116.60M |
| Other Operating Expenses | -15.00M | -14.00M | -8.70M | -7.50M | -12.40M |
| Total Operating Expenses | 2.54B | 2.44B | 2.36B | 2.33B | 2.31B |
| Operating Income | 447.20M | 448.20M | 437.30M | 416.00M | 405.30M |
| Income Before Tax | 125.60M | 147.50M | 164.10M | 135.00M | 115.50M |
| Income Tax Expenses | 19.80M | 18.40M | 5.70M | -300.00K | 3.60M |
| Earnings from Continuing Operations | 105.80 | 129.10 | 158.40 | 135.30 | 111.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -166.40M | -162.90M | -157.80M | -147.20M | -146.20M |
| Net Income | -60.60M | -33.80M | 600.00K | -11.90M | -34.30M |
| EBIT | 447.20M | 448.20M | 437.30M | 416.00M | 405.30M |
| EBITDA | 597.00M | 576.70M | 555.40M | 534.10M | 521.90M |
| EPS Basic | -0.48 | -0.27 | 0.00 | -0.10 | -0.32 |
| Normalized Basic EPS | 0.00 | 0.03 | 0.02 | 0.01 | -0.10 |
| EPS Diluted | -0.48 | -0.27 | 0.00 | -0.10 | -0.32 |
| Normalized Diluted EPS | 0.00 | 0.03 | 0.03 | 0.01 | -0.10 |
| Average Basic Shares Outstanding | 504.05M | 503.63M | 503.21M | 502.45M | 478.56M |
| Average Diluted Shares Outstanding | 504.05M | 503.63M | 504.86M | 504.10M | 480.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
